Fuller & Thaler Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173M | Buy |
1,628,959
+297,948
| +22% | +$31.6M | 0.63% | 37 |
|
|
2025
Q1 | $165M | Buy |
1,331,011
+391,660
| +42% | +$48.6M | 0.64% | 37 |
|
|
2024
Q4 | $116M | Buy |
939,351
+507,234
| +117% | +$62.5M | 0.44% | 72 |
|
|
2024
Q3 | $48.1M | Sell |
432,117
-37,557
| -8% | -$4.18M | 0.19% | 169 |
|
|
2024
Q2 | $50.1M | Sell |
469,674
-615,466
| -57% | -$65.7M | 0.21% | 146 |
|
|
2024
Q1 | $131M | Buy |
+1,085,140
| New | +$131M | 0.57% | 54 |
|
|
2016
Q3 | – | Sell |
-800
| Closed | -$113K | – | 795 |
|
|
2016
Q2 | $113K | Buy |
+800
| New | +$113K | ﹤0.01% | 441 |
|
|
2014
Q4 | – | Sell |
-400
| Closed | -$64K | – | 632 |
|
|
2014
Q3 | $64K | Sell |
400
-400
| -50% | -$64K | ﹤0.01% | 603 |
|
|
2014
Q2 | $118K | Sell |
800
-700
| -47% | -$103K | 0.01% | 564 |
|
|
2014
Q1 | $208K | Buy |
+1,500
| New | +$208K | 0.01% | 428 |
|